Showing 2261-2270 of 3223 results for "".
- Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trialhttps://modernod.com/news/aldeyra-therapeutics-announces-positive-results-from-phase-2b-dry-eye-disease-clinical-trial/2479841/Aldeyra Therapeutics announced positive results from its phase 2b clinical trial of topical ocular reproxalap in patients with dry eye disease. “The early onset and broad activity observed in the phase 2b clinical trial sugg
- National Industries for the Blind Announces New Strategic Alliancehttps://modernod.com/news/national-industries-for-the-blind-announces-new-strategic-alliance/2479842/National Industries for the Blind (NIB) announced a new strategic alliance with the William L. Hudson BVI Workforce Innovation Center to deliver world-class training and professional development for people who are blind. The William L. Hudson BVI Workforce Innovation Center, located in
- Ellex 2RT Retinal Rejuvenation Effective for Select Cases of Intermediate AMDhttps://modernod.com/news/ellex-2rt-retinal-rejuvenation-effective-for-select-cases-of-intermediate-amd/2479852/Ellex Medical Lasers Limited announced the results of the Ellex 2RT Laser Intervention in Age-Related Macular Degeneration (LEAD) multicenter clinical trial. The results of the trial were published in Ophthalmology. According to researchers involved in the LEAD trial, Ellex’s 2RT
- Allergan Announces New Partnership With the International Diabetes Federationhttps://modernod.com/news/allergan-announces-new-partnership-with-the-international-diabetes-federation/2479873/Allergan has announced a collaborative partnership with the International Diabetes Federation (IDF) with the aim of developing a global approach to screen, diagnose, and manage diabetic macular edema (DME). Diabetic eye health is a key concern for IDF and Allergan. The partnership will bri
- Alcon Launches “Alcon Experience Academy” Online Portal for Training and Education for Eye Care Professionalshttps://modernod.com/news/alcon-launches-alcon-experience-academy-online-portal-for-training-and-education-for-eye-care-professionals/2479881/In an effort to provide face-to-face training and online educational resources, Alcon is launching a new online portal,
- Alcon Introduces New AIR OPTIX Plus HydraGlyde Multifocal Contact Lenseshttps://modernod.com/news/alcon-introduces-new-air-optix-plus-hydraglyde-multifocal-contact-lenses/2479894/Alcon is expanding its multifocal portfolio with the launch of AIR OPTIX plus HydraGlyde multifocal contact lenses. As with Alcon’s other multifocal portfolio contact lens options – including DAILIES TOTAL1, DAILIES AquaComfort Plus, and AIR OPTIX AQUA – this latest innovation offers presbyopic p
- Alcon Adds New Ultraviolet-Absorbing Only IOL Options to its AcrySof Portfoliohttps://modernod.com/news/alcon-adds-new-ultraviolet-absorbing-only-iol-options-to-its-acrysof-portfolio/2479895/Alcon expanded its AcrySof IOL portfolio with the introduction of multifocal and multifocal toric ultraviolet (UV)-absorbing IOLs, as well as the introduction of the AcrySof UV-Absorbing monofocal IOL with the UltraSert Preloaded Delivery System. “At Alcon, input from our surgeons is at th
- Alcon to Move Headquarters from Texas to Switzerland Following Proposed Spinoff From Novartishttps://modernod.com/news/alcon-to-move-headquarters-from-texas-to-switzerland-following-proposed-spinoff-from-novartis/2479901/Alcon announced plans to locate its future global headquarters in Geneva, Switzerland, following completion of its proposed spinoff from Novartis, which is expected to be completed in the first half of 2019. Alcon’s new global headquarters in Geneva will be the primary location for A
- Allegro Prepares To Take Lead Compound Risuteganib To Phase 3, Appoints New CEOhttps://modernod.com/news/allegro-prepares-to-take-lead-compound-risuteganib-to-phase-3-appoints-new-ceo/2479926/Allegro Ophthalmics announced that its board of directors has named Hampar Karageozian to the position of Executive Chairman and has appointed Vicken Karageozian, MD, to the position of President and Chief Executive O
- Eye Conditions Provide New Lens for Screening for Alzheimer Diseasehttps://modernod.com/news/eye-conditions-provide-new-lens-for-screening-for-alzheimer-disease/2479952/A study of 3,877 randomly selected patients suggested a significant link between three degenerative eye diseases—age-related macular degeneration, diabetic retinopathy, and glaucoma—and Alzheimer disease. The results offer physicians a new way to detect those at higher risk of this disord